What is Novavax's return on equity?

Novavax (NVAX) reported return on equity of -238.6% in Q1 2022.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Novavax NVAX Return on equity

Discontinued — last reported Q1 '22

Return on equity at other companies

ModernaMRNA

-36.6%+11.9pp

Roivant SciencesROIV

-17.1%-17.7pp

Merck & Co.MRK

19%-20.3pp

Vaxcyte, Inc.PCVX

-30.6%+37.9pp

Viridian Therapeutics, Inc.VRDN

-58.1%+7.9pp

ALN

Alnylam PharmaceuticalsALNY

66.9%—

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+28.6%

Enterprise value$1.53B+68.6%

P/S2.5×+1.5×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Calculated from Novavax’s reported figures.

net income/total stockholders equity=-238.6%

Based on trailing twelve months.

The official record: Novavax’s 10-Q, filed May 10, 2022, on SEC EDGAR. View the filing →

Ask your AI about Novavax's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's return on equity?: Novavax (NVAX) reported return on equity of -238.6% in Q1 2022.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.